PMC:7461420 / 36294-37458
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T198 | 64-72 | Body_part | denotes | cysteine | http://purl.org/sig/ont/fma/fma82751 |
T199 | 386-394 | Body_part | denotes | cysteine | http://purl.org/sig/ont/fma/fma82751 |
T200 | 444-453 | Body_part | denotes | histidine | http://purl.org/sig/ont/fma/fma82755 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T201 | 87-91 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T202 | 620-624 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T203 | 639-648 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T425 | 50-51 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T426 | 167-170 | http://purl.obolibrary.org/obo/CLO_0054060 | denotes | 102 |
T427 | 327-333 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | active |
T428 | 344-345 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T429 | 488-495 | http://purl.obolibrary.org/obo/PR_000018263 | denotes | peptide |
T430 | 528-529 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T431 | 683-690 | http://purl.obolibrary.org/obo/CLO_0009985 | denotes | focused |
T432 | 801-806 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T433 | 808-816 | http://purl.obolibrary.org/obo/PR_000018263 | denotes | Peptides |
T434 | 1015-1023 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T435 | 1065-1073 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T436 | 1130-1138 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T319 | 64-72 | Chemical | denotes | cysteine | http://purl.obolibrary.org/obo/CHEBI_15356 |
T320 | 154-156 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T321 | 386-394 | Chemical | denotes | cysteine | http://purl.obolibrary.org/obo/CHEBI_15356 |
T322 | 407-418 | Chemical | denotes | nucleophile | http://purl.obolibrary.org/obo/CHEBI_59740 |
T323 | 444-453 | Chemical | denotes | histidine | http://purl.obolibrary.org/obo/CHEBI_27570 |
T324 | 473-477 | Chemical | denotes | acid | http://purl.obolibrary.org/obo/CHEBI_37527 |
T325 | 478-482 | Chemical | denotes | base | http://purl.obolibrary.org/obo/CHEBI_22695 |
T326 | 488-495 | Chemical | denotes | peptide | http://purl.obolibrary.org/obo/CHEBI_16670 |
T327 | 509-518 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
T328 | 558-560 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T329 | 694-713 | Chemical | denotes | protease inhibitors | http://purl.obolibrary.org/obo/CHEBI_37670|http://purl.obolibrary.org/obo/CHEBI_60258 |
T331 | 703-713 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
T332 | 751-755 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T333 | 818-833 | Chemical | denotes | peptidomimetics | http://purl.obolibrary.org/obo/CHEBI_63175 |
T334 | 850-859 | Chemical | denotes | molecules | http://purl.obolibrary.org/obo/CHEBI_25367 |
T335 | 978-987 | Chemical | denotes | molecules | http://purl.obolibrary.org/obo/CHEBI_25367 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T55 | 426-437 | http://purl.obolibrary.org/obo/GO_0006508 | denotes | proteolysis |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1126 | 37-41 | Gene | denotes | Mpro | Gene:8673700 |
1127 | 33-36 | Species | denotes | CoV | Tax:11118 |
1138 | 42-46 | Gene | denotes | Mpro | Gene:8673700 |
1139 | 322-326 | Gene | denotes | Mpro | Gene:8673700 |
1140 | 98-102 | Gene | denotes | Mpro | Gene:8673700 |
1141 | 87-95 | Species | denotes | SARS‐CoV | Tax:694009 |
1142 | 318-321 | Species | denotes | CoV | Tax:11118 |
1143 | 64-81 | Gene | denotes | cysteine protease | Gene:1508 |
1144 | 362-368 | Chemical | denotes | Cys145 | |
1145 | 369-374 | Chemical | denotes | His41 | |
1146 | 386-394 | Chemical | denotes | cysteine | MESH:D003545 |
1147 | 444-453 | Chemical | denotes | histidine | MESH:D006639 |
1150 | 1011-1014 | Species | denotes | CoV | Tax:11118 |
1151 | 635-648 | Disease | denotes | CoV infection | MESH:D018352 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T335 | 0-41 | Sentence | denotes | 3.1.1 Structure and function of CoV Mpro |
T336 | 42-82 | Sentence | denotes | Mpro is a homodimeric cysteine protease. |
T337 | 83-129 | Sentence | denotes | The SARS‐CoV‐1 Mpro consists of three domains: |
T338 | 130-308 | Sentence | denotes | I (residues 8–101), and II (residues 102–184), which are β‐barrel domains that shape the chymotrypsin‐like structure, while domain III (residues 201–306) is made up by α‐helices. |
T339 | 309-483 | Sentence | denotes | 124 The CoV Mpro active site uses a catalytic dyad (Cys145‐His41), in which cysteine acts as the nucleophile in the proteolysis while histidine behaves as general acid‐base. |
T340 | 484-561 | Sentence | denotes | The peptide substrate or inhibitor binds in a cleft between domains I and II. |
T341 | 562-565 | Sentence | denotes | 125 |
T342 | 566-714 | Sentence | denotes | As far as the development of new therapeutics against SARS‐ and MERS‐CoV infection is concerned, efforts have mainly focused on protease inhibitors. |
T343 | 715-807 | Sentence | denotes | These enzymes are highly attractive drug targets because they are so essential to the virus. |
T344 | 808-947 | Sentence | denotes | Peptides, peptidomimetics, and even small molecules can inhibit them, which leads to markedly reduced viral transmission and pathogenicity. |
T345 | 948-1139 | Sentence | denotes | Although most of the reported molecules display only weak anti‐CoV activity, several of studies elucidated structure–activity relationships that can be used to further improve their activity. |
T346 | 1140-1164 | Sentence | denotes | 100 , 126 , 127 , 128 |